A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial.Timothy Devos, Geert Meyfroidt, Cyril Barbezange et al.|Research Square|2020Cited by 2
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial.Timothy Devos, Geert Meyfroidt, Tatjana Geukens et al.|Research Square|2020Cited by 1